Literature DB >> 24771842

Introducing genetic testing for cardiovascular disease in primary care: a qualitative study.

Jo B Middlemass1, Momina F Yazdani, Joe Kai, Penelope J Standen, Nadeem Qureshi.   

Abstract

BACKGROUND: While primary care systematically offers conventional cardiovascular risk assessment, genetic tests for coronary heart disease (CHD) are increasingly commercially available to patients. It is unclear how individuals may respond to these new sources of risk information. AIM: To explore how patients who have had a recent conventional cardiovascular risk assessment, perceive additional information from genetic testing for CHD. DESIGN AND
SETTING: Qualitative interview study in 12 practices in Nottinghamshire from both urban and rural settings.
METHOD: Interviews were conducted with 29 adults, who consented to genetic testing after having had a conventional cardiovascular risk assessment.
RESULTS: Individuals' principal motivation for genetic testing was their family history of CHD and a desire to convey the results to their children. After testing, however, there was limited recall of genetic test results and scepticism about the value of informing their children. Participants dealt with conflicting findings from the genetic test, family history, and conventional assessment by either focusing on genetic risk or environmental lifestyle factors. In some participants, genetic test results appeared to reinforce healthy behaviour but others were falsely reassured, despite having an 'above-average' conventional cardiovascular risk score.
CONCLUSION: Although genetic testing was acceptable, participants were unclear how to interpret genetic risk results. To facilitate healthy behaviour, health professionals should explore patients' understanding of genetic test results in light of their family history and conventional risk assessment.

Entities:  

Keywords:  coronary heart disease; family practice; genetic testing; primary health care

Mesh:

Year:  2014        PMID: 24771842      PMCID: PMC4001138          DOI: 10.3399/bjgp14X679714

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  33 in total

Review 1.  Coronary heart disease risk prediction in the era of genome-wide association studies: current status and what the future holds.

Authors:  Steve E Humphries; Fotios Drenos; Gie Ken-Dror; Philippa J Talmud
Journal:  Circulation       Date:  2010-05-25       Impact factor: 29.690

2.  The contribution of the Framingham Heart Study to the prevention of cardiovascular disease: a global perspective.

Authors:  Shanthi Mendis
Journal:  Prog Cardiovasc Dis       Date:  2010 Jul-Aug       Impact factor: 8.194

3.  Impact of genetic risk information and type of disease on perceived risk, anticipated affect, and expected consequences of genetic tests.

Authors:  Linda D Cameron; Kerry A Sherman; Theresa M Marteau; Paul M Brown
Journal:  Health Psychol       Date:  2009-05       Impact factor: 4.267

4.  'Over-the-counter' genetic testing: what does it really mean for primary care?

Authors:  Imran Rafi; Nadeem Qureshi; Anneke Lucassen; Michael Modell; Frances Elmslie; Joe Kai; Maggie Kirk; Nigel Starey; Sheila Goff; Paul Brennan; Shirley Hodgson
Journal:  Br J Gen Pract       Date:  2009-04       Impact factor: 5.386

Review 5.  The behavioral response to personalized genetic information: will genetic risk profiles motivate individuals and families to choose more healthful behaviors?

Authors:  Colleen M McBride; Laura M Koehly; Saskia C Sanderson; Kimberly A Kaphingst
Journal:  Annu Rev Public Health       Date:  2010       Impact factor: 21.981

6.  Effect of direct-to-consumer genomewide profiling to assess disease risk.

Authors:  Cinnamon S Bloss; Nicholas J Schork; Eric J Topol
Journal:  N Engl J Med       Date:  2011-01-12       Impact factor: 91.245

7.  Educational needs of primary care physicians regarding direct-to-consumer genetic testing.

Authors:  Karen P Powell; Carol A Christianson; Whitney A Cogswell; Gaurav Dave; Amit Verma; Sonja Eubanks; Vincent C Henrich
Journal:  J Genet Couns       Date:  2011-12-30       Impact factor: 2.537

Review 8.  Translating genomic analyses into improved management of coronary artery disease.

Authors:  Christopher T Johansen; Matthew B Lanktree; Robert A Hegele
Journal:  Future Cardiol       Date:  2010-07

Review 9.  Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours.

Authors:  Theresa M Marteau; David P French; Simon J Griffin; A T Prevost; Stephen Sutton; Clare Watkinson; Sophie Attwood; Gareth J Hollands
Journal:  Cochrane Database Syst Rev       Date:  2010-10-06

10.  Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using QResearch database.

Authors:  Julia Hippisley-Cox; Carol Coupland; John Robson; Peter Brindle
Journal:  BMJ       Date:  2010-12-09
View more
  7 in total

1.  Polygenic risk scores: improving the prediction of future disease or added complexity?

Authors:  Aya Ayoub; Jana McHugh; Judith Hayward; Imran Rafi; Nadeem Qureshi
Journal:  Br J Gen Pract       Date:  2022-07-28       Impact factor: 6.302

2.  Chronic disease prevention in primary care: how and when will genomics impact?

Authors:  Fiona M Walter; Jon Emery; Hilary Burton
Journal:  Br J Gen Pract       Date:  2014-07       Impact factor: 5.386

3.  Acceptability of predictive testing for ischemic heart disease in those with a family history and the impact of results on behavioural intention and behaviour change: a systematic review.

Authors:  Imogen Wells; Gwenda Simons; Clare Davenport; Christian D Mallen; Karim Raza; Marie Falahee
Journal:  BMC Public Health       Date:  2022-09-15       Impact factor: 4.135

Review 4.  Cardiovascular risk communication strategies in primary prevention. A systematic review with narrative synthesis.

Authors:  Stacey D Schulberg; Amy V Ferry; Kai Jin; Lucy Marshall; Lis Neubeck; Fiona E Strachan; Nicholas L Mills
Journal:  J Adv Nurs       Date:  2022-06-19       Impact factor: 3.057

5.  Information and Risk Modification Trial (INFORM): design of a randomised controlled trial of communicating different types of information about coronary heart disease risk, alongside lifestyle advice, to achieve change in health-related behaviour.

Authors:  Barbora Silarova; Joanne Lucas; Adam S Butterworth; Emanuele Di Angelantonio; Christine Girling; Kathryn Lawrence; Stuart Mackintosh; Carmel Moore; Rupert A Payne; Stephen J Sharp; Guy Shefer; Zoe Tolkien; Juliet Usher-Smith; Matthew Walker; John Danesh; Simon Griffin
Journal:  BMC Public Health       Date:  2015-09-07       Impact factor: 3.295

6.  The response to receiving phenotypic and genetic coronary heart disease risk scores and lifestyle advice - a qualitative study.

Authors:  Guy Shefer; Barbora Silarova; Juliet Usher-Smith; Simon Griffin
Journal:  BMC Public Health       Date:  2016-12-03       Impact factor: 3.295

7.  Case-finding and genetic testing for familial hypercholesterolaemia in primary care.

Authors:  Nadeem Qureshi; Ralph Kwame Akyea; Stephen F Weng; Joe Kai; Brittany Dutton; Steve E Humphries; Hasidah Abdul Hamid; Laura Condon
Journal:  Heart       Date:  2021-09-14       Impact factor: 5.994

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.